China insurers drive stock selloff, PBOC steps in

What makes this rout different is that the selling appears less about leveraged speculation and foreign outflows than about insurers trimming exposure after being pushed into equities by policymakers. Margin financing has already fallen, and northbound turnover through Stock Connect has weakened, pointing away from the hedge funds and overseas traders usually blamed for Chinese volatility. That leaves domestic insurers, which have increased stock allocations in search of yield and under policy pressure to provide long-term capital to the market.

China Life Insurance had raised its equity allocation to 19.2% of portfolio assets by end-June, up from 16.9% in 2025, underscoring how deeply insurers had leaned into the government’s equity-support campaign. But insurers are not a permanent backstop. They must protect solvency, meet claims and preserve short-term portfolio performance, which makes them far less countercyclical than the state’s market-stabilisation arm. China Pacific Insurance Group has already described equity investing as “complicated,” while profits at the five major listed insurers fell sharply in the third quarter, largely because of the slump in domestic shares.

That is why the current episode matters for investors beyond China’s borders. It shows Beijing’s market-support model can become self-defeating: if the state pushes insurers into equities, those same insurers may eventually become forced sellers when valuations crack. The result is a feedback loop in which policy support props up risk assets for a time, then amplifies volatility when institutional balance sheets come under pressure. For global investors, that raises questions about whether rallies in China can be trusted without continuous official support.

The market backdrop also helps explain why the pain has concentrated in technology. The STAR 50’s near-halving from its peak reflects the unwind of a momentum trade that has already suffered violent reversals in China, South Korea and the US. Semiconductor names in particular are vulnerable because they are capital-intensive, cyclical and richly valued relative to the more defensive domestic stocks insurers may ultimately prefer, such as dividend-paying banks. That comparison matters: in a market increasingly shaped by policy rather than pure fundamentals, capital is being steered toward assets that fit liability management, not necessarily the highest-growth sectors the state wants to champion.

For Beijing, the immediate challenge is to arrest the decline without admitting the policy mix is part of the problem. For investors, the key question is whether the latest rescue can stabilise prices long enough to restore confidence — or whether China is once again treating the symptom rather than the cause of its repeated equity crashes.